We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$202M
AUM Growth
-$10.1M
(-4.7%)
Cap. Flow
+$30.2M
Cap. Flow
% of AUM
14.92%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
66
New
5
Increased
31
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$5.4M |
| 2 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$4.95M |
| 3 |
AtriCure
ATRC
|
+$3.16M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$2.95M |
| 5 |
Arrowhead Research
ARWR
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$7.83M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
+$3.38M |
| 3 |
Standard BioTools
LAB
|
+$2.38M |
| 4 |
Verastem
VSTM
|
+$1.72M |
| 5 |
ELGX
Endologix Inc
ELGX
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.82% |
| 2 | Energy | 3.37% |
| 3 | Real Estate | 2.4% |
| 4 | Financials | 0.28% |
| 5 | Consumer Staples | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Viatris
VTRS
$20.4B
| $394K | 0.19% |
9,775
| – | – |
|
|
STJ
52
DELISTED
St Jude Medical
STJ
| $382K | 0.19% |
6,055
| – | – |
|
53
AstraZeneca
AZN
$263B
| $361K | 0.18% |
5,680
| – | – |
|
54
Johnson & Johnson
JNJ
$618B
| $357K | 0.18% |
3,820
| – | – |
|
55
Pfizer
PFE
$143B
| $330K | 0.16% |
11,088
| – | – |
|
56
Merck
MRK
$322B
| $326K | 0.16% |
6,927
| – | – |
|
57
Amgen
AMGN
$208B
| $322K | 0.16% |
2,330
| – | – |
|
58
Myriad Genetics
MYGN
$270M
| $293K | 0.14% |
7,820
| – | – |
|
59
Sanofi
SNY
$103B
| $270K | 0.13% |
5,680
| – | – |
|
60
Community Health Systems
CYH
$393M
| $263K | 0.13% |
7,435
| – | – |
|
|
STKL
61
DELISTED
SunOpta
STKL
| $244K | 0.12% |
50,230
-111,460
| -69% | -$1.01M |
|
62
Bio-Rad Laboratories Class A
BIO
$8.71B
| $225K | 0.11% |
1,675
| – | – |
|
63
Cytokinetics
CYTK
$10.5B
| – | – |
-218,792
| Closed | -$1.47M |
|
|
64
Standard BioTools
LAB
$340M
| – | – |
-98,209
| Closed | -$2.38M |
|
|
65
Verastem
VSTM
$510M
| – | – |
-19,045
| Closed | -$1.72M |
|
|
AMAG
66
DELISTED
AMAG Pharmaceuticals
AMAG
| – | – |
-113,368
| Closed | -$7.83M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, First Light Asset Management held 66 positions worth $202M, down 4.7% from $212M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management deployed $30.2M of net new capital in Q3 2015, opening 5 new positions and adding to 31 existing holdings. Its largest new stake was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Energy and Real Estate.
On the sell side, the largest reduction was NxStage Medical Inc., an estimated $3.38M trimmed.
- First Light Asset Management's largest Q3 2015 buy was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
- First Light Asset Management added most to AtriCure in Q3 2015, an estimated $3.16M increase.
- First Light Asset Management's biggest Q3 2015 reduction was NxStage Medical Inc., cutting an estimated $3.38M.
- First Light Asset Management fully exited AMAG Pharmaceuticals in Q3 2015, selling an estimated $7.83M.
- First Light Asset Management's ten largest holdings make up 49% of its $202M portfolio in Q3 2015.
- First Light Asset Management opened 5 new positions and closed 4 in Q3 2015.
- First Light Asset Management's portfolio value fell 4.7% quarter-over-quarter to $202M.
Based on First Light Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.